LUTZ PIERRE: Open Payments
NPI 1598509150 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,960 in 240 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,460 · 2025 $4,960
Food & beverage: $4,849Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $641 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $614 |
| Vanda Pharmaceuticals Inc. | 21 | $460 |
| Neurocrine BioSciences, Inc. | 20 | $433 |
| Otsuka America Pharmaceutical, Inc. | 10 | $334 |
| Axsome Therapeutics, Inc. | 17 | $318 |
| Supernus Pharmaceuticals, Inc. | 13 | $306 |
| Janssen Pharmaceuticals, Inc | 17 | $302 |
| Alkermes, Inc. | 15 | $249 |
| ABBVIE INC. | 14 | $224 |
Products named: CAPLYTA, AUSTEDO XR, FANAPT, INGREZZA, REXULTI, Auvelity, Qelbree, ARISTADA.
Industry payments across NC — which companies pay providers there.
